MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
- PMID: 35659780
- PMCID: PMC9167543
- DOI: 10.1186/s40364-022-00382-4
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
Abstract
Thyroid cancer (TC) is one of the most frequent endocrine malignancies that is more common among females. Tumor recurrence is one of the most important clinical manifestations in differentiated TC which is associated with different factors including age, tumor size, and histological features. Various molecular processes such as genetic or epigenetic modifications and non-coding RNAs are also involved in TC progression and metastasis. The epithelial-to-mesenchymal transition (EMT) is an important biological process during tumor invasion and migration that affects the initiation and transformation of early-stage tumors into invasive malignancies. A combination of transcription factors, growth factors, signaling pathways, and epigenetic regulations affect the thyroid cell migration and EMT process. MicroRNAs (miRNAs) are important molecular factors involved in tumor metastasis by regulation of EMT-activating signaling pathways. Various miRNAs are involved in the signaling pathways associated with TC metastasis which can be used as diagnostic and therapeutic biomarkers. Since, the miRNAs are sensitive, specific, and non-invasive, they can be suggested as efficient and optimal biomarkers of tumor invasion and metastasis. In the present review, we have summarized all of the miRNAs which have been significantly involved in thyroid tumor cells migration and invasion. We also categorized all of the reported miRNAs based on their cellular processes to clarify the molecular role of miRNAs during thyroid tumor cell migration and invasion. This review paves the way of introducing a non-invasive diagnostic and prognostic panel of miRNAs in aggressive and metastatic TC patients.
Keywords: Invasion; Metastasis; Migration; Panel marker; Thyroid cancer; miRNA.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.Heliyon. 2024 May 1;10(9):e30599. doi: 10.1016/j.heliyon.2024.e30599. eCollection 2024 May 15. Heliyon. 2024. PMID: 38726188 Free PMC article. Review.
-
Role of microRNAs in endocrine cancer metastasis.Mol Cell Endocrinol. 2017 Nov 15;456:62-75. doi: 10.1016/j.mce.2017.03.015. Epub 2017 Mar 18. Mol Cell Endocrinol. 2017. PMID: 28322989 Review.
-
MicroRNAs and epithelial-mesenchymal transition in prostate cancer.Oncotarget. 2016 Oct 11;7(41):67597-67611. doi: 10.18632/oncotarget.11708. Oncotarget. 2016. PMID: 27588490 Free PMC article. Review.
-
microRNA signature for human pancreatic cancer invasion and metastasis.Exp Ther Med. 2012 Aug;4(2):181-187. doi: 10.3892/etm.2012.585. Epub 2012 May 21. Exp Ther Med. 2012. PMID: 22970025 Free PMC article.
-
lncRNA ZNF674-AS1 inhibits the migration, invasion and epithelial-mesenchymal transition of thyroid cancer cells by modulating the miR-181a/SOCS4 axis.Mol Cell Endocrinol. 2022 Mar 15;544:111551. doi: 10.1016/j.mce.2021.111551. Epub 2022 Jan 4. Mol Cell Endocrinol. 2022. PMID: 34990740
Cited by
-
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma.Mol Brain. 2024 Jul 2;17(1):42. doi: 10.1186/s13041-024-01113-6. Mol Brain. 2024. PMID: 38956588 Free PMC article. Review.
-
Immune-related long noncoding RNA zinc finger protein 710-AS1-201 promotes the metastasis and invasion of gastric cancer cells.World J Gastrointest Oncol. 2024 Feb 15;16(2):458-474. doi: 10.4251/wjgo.v16.i2.458. World J Gastrointest Oncol. 2024. PMID: 38425400 Free PMC article.
-
Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer.Front Med (Lausanne). 2023 Apr 5;10:1139362. doi: 10.3389/fmed.2023.1139362. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37089590 Free PMC article. Review.
-
A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence.Cancers (Basel). 2022 Aug 26;14(17):4128. doi: 10.3390/cancers14174128. Cancers (Basel). 2022. PMID: 36077665 Free PMC article.
-
Intracellular FGF1 promotes invasion and migration in thyroid carcinoma via HMGA1 independent of FGF receptors.Endocr Connect. 2023 Apr 26;12(5):e230014. doi: 10.1530/EC-23-0014. Print 2023 May 1. Endocr Connect. 2023. PMID: 36952626 Free PMC article.
References
-
- Goodarzi E, et al. Epidemiology, incidence and mortality of thyroid cancer and their relationship with the human development index in the world: an ecology study in 2018. Adv Hum Biology. 2019;9(2):162. doi: 10.4103/AIHB.AIHB_2_19. - DOI
Publication types
LinkOut - more resources
Full Text Sources